BRX-10030

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameBRX-10030

Drug Alias Namerunt-related transcription factor 3 inhibitor (Biorunx)RUNX3 inhibitor (Biorunx)BRX-10030

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionRunt-related transcription factor 3 inhibitors

TargetsRunt-related transcription factor 3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiorunx

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiorunx

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A